Short answer
QuidelOrtho Corp (QDEL) filed an 8-K current report with the SEC on May 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q1 2026 results for quarter ended March 29, 2026 announced May 5, 2026.
QuidelOrtho Corp 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 results for quarter ended March 29, 2026 announced May 5, 2026
- Earnings conference call scheduled for 2:00 p.m. Pacific Time on May 5, 2026
- Press release furnished as Exhibit 99.1, containing the substantive financial results
- Disclosure furnished rather than filed, limiting Section 18 liability and incorporation by reference
Item EX-99.1 · Exhibit EX-99.1
- Q1 revenue $619.8M, down 10.5%; Point of Care fell 34.0% amid a weaker respiratory season
- GAAP net loss $91.8M versus $12.7M loss; adjusted EBITDA $108.7M versus $159.8M
- Operating cash flow turned negative at $33.0M versus $65.6M positive, reducing cash to $140.4M
- 2026 revenue guidance narrowed to $2.70–$2.75B from $2.7–$2.9B, reflecting China pricing uncertainty
- Guidance cuts: adjusted EBITDA $615–$630M, EPS $1.80–$2.00, free cash flow $100–$120M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other QuidelOrtho Corp 8-K filings
Get the next QDEL 8-K as it lands
Follow QDEL for push alerts, or ask the research agent what this filing means.